Becton, Dickinson and (NYSE:BDX) Releases Quarterly Earnings Results, Beats Expectations By $0.30 EPS
Becton, Dickinson and (NYSE:BDX) Releases Quarterly Earnings Results, Beats Expectations By $0.30 EPS
Becton, Dickinson and (NYSE:BDX – Get Rating) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $2.98 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.30, RTT News reports. Becton, Dickinson and had a return on equity of 13.52% and a net margin of 8.47%. The company had revenue of $4.59 billion during the quarter, compared to analyst estimates of $4.59 billion. During the same quarter last year, the firm posted $3.64 EPS. The firm's revenue for the quarter was down 2.8% on a year-over-year basis. Becton, Dickinson and updated its FY23 guidance to $12.07 to $12.32 EPS and its FY 2023 guidance to $12.07-$12.32 EPS.
周四,Becton、Dickinson和(NYSE:BDX-GET Rating)公布了季度收益数据。据RTT新闻报道,这家医疗器械供应商公布了本季度每股收益2.98美元,比普遍预期的2.68美元高出0.30美元。Becton、Dickinson和拥有13.52%的股本回报率和8.47%的净利润率。该公司本季度营收为45.9亿美元,而分析师预期为45.9亿美元。去年同一季度,该公司公布的每股收益为3.64美元。该公司本季度的收入同比下降了2.8%。并将其23财年每股收益指引更新为12.07美元至12.32美元,将2023财年每股收益指引更新为12.07美元至12.32美元。
Becton, Dickinson and Trading Down 1.1 %
Becton,Dickinson和Trading下跌1.1%
BDX stock traded down $2.63 during trading on Friday, hitting $245.84. 2,117,947 shares of the company traded hands, compared to its average volume of 1,115,617. The firm has a market capitalization of $69.88 billion, a PE ratio of 46.38, a P/E/G ratio of 2.13 and a beta of 0.54. Becton, Dickinson and has a 1 year low of $215.90 and a 1 year high of $280.62. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.63 and a current ratio of 1.07. The company has a 50-day moving average of $251.67 and a 200-day moving average of $244.48.
在周五的交易中,BDX的股价下跌了2.63美元,跌至245.84美元。该公司有2,117,947股易手,而其平均成交量为1,115,617股。该公司市值为698.8亿美元,市盈率为46.38,市盈率为2.13,贝塔系数为0.54。贝顿,迪金森,并有一年的低点215.90美元和一年的高点280.62美元。该公司的负债权益比率为0.56,速动比率为0.63,流动比率为1.07。该公司的50日移动均线切入位在251.67美元,200日移动均线切入位在244.48美元。
Becton, Dickinson and Announces Dividend
Becton,Dickinson和宣布分红
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 31st. Stockholders of record on Friday, March 10th will be issued a $0.91 dividend. The ex-dividend date is Thursday, March 9th. This represents a $3.64 dividend on an annualized basis and a dividend yield of 1.48%. Becton, Dickinson and's payout ratio is 68.68%.
该公司最近还披露了季度股息,将于3月31日(星期五)支付。3月10日(星期五)登记在册的股东将获得0.91美元的股息。除息日期为3月9日(星期四)。这意味着年化股息为3.64美元,股息收益率为1.48%。Becton,Dickinson and的派息率为68.68%。
Analyst Upgrades and Downgrades
分析师升级和下调评级
Institutional Trading of Becton, Dickinson and
贝顿、迪金森和
A number of institutional investors have recently modified their holdings of BDX. Kayne Anderson Rudnick Investment Management LLC lifted its position in Becton, Dickinson and by 18.2% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 94,253 shares of the medical instruments supplier's stock valued at $21,003,000 after buying an additional 14,501 shares during the period. Captrust Financial Advisors raised its position in Becton, Dickinson and by 7.3% in the 3rd quarter. Captrust Financial Advisors now owns 87,783 shares of the medical instruments supplier's stock worth $19,561,000 after buying an additional 5,986 shares during the last quarter. CreativeOne Wealth LLC raised its holdings in shares of Becton, Dickinson and by 6.5% during the third quarter. CreativeOne Wealth LLC now owns 2,565 shares of the medical instruments supplier's stock valued at $572,000 after purchasing an additional 157 shares during the last quarter. Jane Street Group LLC increased its position in Becton, Dickinson and by 136.7% during the third quarter. Jane Street Group LLC now owns 34,591 shares of the medical instruments supplier's stock valued at $7,708,000 after acquiring an additional 19,978 shares during the last quarter. Finally, Wealthsource Partners LLC purchased a new stake in Becton, Dickinson and during the third quarter valued at approximately $208,000. 87.08% of the stock is currently owned by hedge funds and other institutional investors.
一些机构投资者最近调整了对BDX的持股。Kayne Anderson Rudnick Investment Management LLC在第三季度将其在Becton,Dickinson的头寸提高了18.2%。Kayne Anderson Rudnick Investment Management LLC现在持有这家医疗器械供应商94,253股股票,价值21,003,000美元,在此期间又购买了14,501股。CapTrust Financial Advisors在第三季度将其在Becton,Dickinson的头寸提高了7.3%。CapTrust Financial Advisors现在拥有这家医疗器械供应商87,783股股票,价值19,561,000美元,上个季度又购买了5,986股。CreativeOne Wealth LLC在第三季度增持了Becton,Dickinson的股票,并增加了6.5%的股份。CreativeOne Wealth LLC现在拥有这家医疗器械供应商2,565股股票,价值572,000美元,上个季度又购买了157股。简街集团在第三季度增加了其在贝顿,迪金森的头寸,增加了136.7%。简街集团现在拥有这家医疗器械供应商34,591股股票,价值7,708,000美元,在上个季度额外收购了19,978股。最后,Wealthource Partners LLC在第三季度购买了Becton,Dickinson的新股份,价值约20.8万美元。87.08%的股票目前由对冲基金和其他机构投资者持有。
Becton, Dickinson and Company Profile
贝顿、狄金森和公司简介
(Get Rating)
(获取评级)
Becton, Dickinson & Co engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery.
Becton,Dickinson&Co从事医疗用品、设备、实验室设备和诊断产品的开发、制造和销售。它通过以下部门开展业务:BD医疗、BD生命科学和BD Intervative。BD医疗部门生产医疗技术和设备,用于帮助改善医疗保健服务。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Becton, Dickinson and (BDX)
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- 免费获取StockNews.com关于Becton、Dickinson和(BDX)的研究报告
- 市场回顾周-1/30-2/3
- 细价股值得吗?你应该投资细价股吗?
- Zimmer Biomet盈利节节攀升,增长可能被计入价格
- 人工智能软件制造商EPAM号称科技板块涨幅最大
- 福特股票在盈利大幅下滑后继续前进
Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.
接受Becton Dickinson和Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Becton Dickinson和相关公司的最新新闻和分析师评级的每日简要摘要。